Screening for pre-eclampsia in our low-risk population at 24 weeks: Uterine artery Doppler flow velocimetry and factor V, prothrombin and methylenetetrahydrofolate reductase gene variants;Screening per la pre-eclampsia in pazienti a basso rischio alla ventiquattresima settimana: Flussimetria delle arterie uterine e varianti geniche del fattore V, della protrombina e della metilentetraidrofolato reduttasi

Minerva Ginecologica

Volumn 56, Issue 5, 2004, Pages 385-390

  Driul, L ^a   Damante, G ^a   D'Elia, A ^a   Springolo, F ^a   Ianni, A ^a   Di Leonardo, C ^a   Angelini, M ^a   Marchesoni, D ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Gnetics; Preeclampsia; Risk factors; Ultrasonography

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DOPPLER FLOWMETRY; FEMALE; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; PREECLAMPSIA; PREGNANCY; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; UTERINE ARTERY;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FACTOR V; FEMALE; HUMANS; MASS SCREENING; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; POLYMERASE CHAIN REACTION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROTHROMBIN; PULSATILE FLOW; RETROSPECTIVE STUDIES; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER; UTERUS;

EID: 11144299598     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J. The detection, investigation and management of hypertension in pregnancy. Aust N Z Obstet Gynecol 2000;40:2:133-55.
2. Kong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregancies complicated by pre-eclampsia and by small for-gestational age infants. Br J Obstet Gynecol 1986;93:1049-59.
3. Pijnenborg R, Dixon G, Robertson WB, Brosens I. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1980;1:3-19.
4. Ekholm E. Hemodynamic measures in prediction of pre-eclampsia. Acta Obstet Gynecol Scand Suppl 1997; 164:101-3.
5. Chien PF, Arnott N, Gordon A, Owen P, Kann KS. How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview. Br J Obstet Gynaecol 2000;107:196-208.
6. Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000;96: 45-9.
7. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
8. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. ACOG technical bulletin no. 219. Washington DC: American College of Obstetricians and Gynecologists; 1996.
9. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, De Rhonde H et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
10. Arruda VR, Annichilo-Bizzacchi JM, Goncalves MS. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997;78:1430-3.
11. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG et al. A candidate genetic risk factor for vascular disease: a common mutation in methylentetrahydrofolate reductase. Nat Genet 1995;10:111-3.
12. Dekker GA, Sibai BM. Early detection of preeclampsia. Am J Obstet Gynaecol 1991;165:160-72.
13. Irion O, Massè J, Forest J-C, Moutquin J-M. Prediction of preeclampsia, low birthweight for gestation and prematurity by uterine artery blood flow velocity waveform analysis in low risk nulliparous women. Br J Obstet Gynaecol 1998;105:422-9.
14. Campbell S, Pearce J, Hackett G, Cohen-Overbeek T, Hernandez C. Qualitative assessment of uteroplacental blood flow; early screening test for high risk pregancies. Obstet Gynecol 1986;68:649-53.
15. Bower S, Schuchter K, Campbell S. Doppler ultrasound screening as part of routine antenatal scanning: prediction of pre-eclampsia and intrauterine growth retardation. Br J Obstet Gynecol 1993;100:989-94.
16. Glueck CJ, Kupferminc MJ, Fontaine RN, Wang P, Weksler BB, Eldor A. Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol 2001;97:44-8.
17. Lockwood CJ. Heritable coagulopathies in pregnancy. Obstet Gynecol Surv 1999;54:754-65.
18. De Groot CJ, Bloemenkamp KW, Duvekot EJ, Heimerhorst FM, Bertina RM, Van Der Meer F et al. Preeclampsia and genetic risk factors for thrombosis: a case-control study. Am J Obstet Gynecol 1999;181: 975-80.
19. Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 2000;96:559-64.
20. Antsaklis A, Daskalakis G, Tzortzis E, Michalas S. The effect of gestational age and placental location on the prediction of pre-eclampsia by uterine artery Doppler velocimetry in low-risk nulliparous women. Ultrasound Obstet Gynecol 2000;16:635-9.
21. Dizon-Townson DS, Nelson LM, Easton K, Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996;175:902-5.
22. Van Pampus MG, Dekker GA, Wolf H, Huijgens PC, Koopman MMW. High prevalence of hemostatic abnormalities in women with a history of preeclampsia. Am J Obstet Gynecol 1999;180:1146-50.
23. Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P. Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 1997;77:1052-4.
24. O'Shaughnessy KM, Fu B, Ferraro F, Lewis I, Downing S, Morris NH. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort. Hypertension 1999;33: 1338-41.